MCID: UTR006
MIFTS: 16

Uterine Inflammatory Disease

Categories: Reproductive diseases

Aliases & Classifications for Uterine Inflammatory Disease

MalaCards integrated aliases for Uterine Inflammatory Disease:

Name: Uterine Inflammatory Disease 12 14
Inflammatory Disease of the Uterus 12 69

Classifications:



External Ids:

Disease Ontology 12 DOID:13736
ICD10 33 N71.9
ICD9CM 35 615.9
UMLS 69 C0269047

Summaries for Uterine Inflammatory Disease

MalaCards based summary : Uterine Inflammatory Disease, is also known as inflammatory disease of the uterus. An important gene associated with Uterine Inflammatory Disease is YBX3 (Y-Box Binding Protein 3). The drugs Clindamycin and Povidone have been mentioned in the context of this disorder. Affiliated tissues include uterus, myeloid and cervix.

Related Diseases for Uterine Inflammatory Disease

Diseases in the Uterine Disease family:

Uterine Inflammatory Disease

Comorbidity relations with Uterine Inflammatory Disease via Phenotypic Disease Network (PDN):


Acute Cystitis

Symptoms & Phenotypes for Uterine Inflammatory Disease

Drugs & Therapeutics for Uterine Inflammatory Disease

Drugs for Uterine Inflammatory Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 119)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
2
Povidone Approved Phase 4,Phase 3 9003-39-8
3 Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
4
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
5
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
6
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
7
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
8
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
9
Cefazolin Approved Phase 4 25953-19-9 656510 33255
10
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
11
Iodine Investigational Phase 4,Phase 3,Phase 2 7553-56-2 807
12 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1
13 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1
14 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
15 Antitubercular Agents Phase 4,Phase 2,Phase 3
16 Clindamycin palmitate Phase 4
17 Clindamycin phosphate Phase 4
18 Gentamicins Phase 4,Phase 2,Phase 3
19 Vaccines Phase 4,Phase 3
20 Anti-Infective Agents, Local Phase 4,Phase 3,Phase 2
21 Blood Substitutes Phase 4,Phase 3
22 cadexomer iodine Phase 4,Phase 3,Phase 2
23 Micronutrients Phase 4,Phase 3,Phase 2
24 Pharmaceutical Solutions Phase 4,Phase 3
25 Plasma Substitutes Phase 4,Phase 3
26 Trace Elements Phase 4,Phase 3,Phase 2
27 Antimalarials Phase 4
28 Antiparasitic Agents Phase 4
29 Antiprotozoal Agents Phase 4
30 Analgesics Phase 4,Phase 3,Phase 1,Phase 2
31 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 1,Phase 2
32 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 1,Phase 2
33 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 1,Phase 2
34 Antirheumatic Agents Phase 4,Phase 3,Phase 1,Phase 2
35 Contraceptive Agents Phase 4,Phase 3,Phase 1,Phase 2
36 Contraceptives, Oral Phase 4,Phase 3
37 Contraceptives, Oral, Combined Phase 4,Phase 3
38 Cyclooxygenase Inhibitors Phase 4,Phase 3
39 Estradiol 17 beta-cypionate Phase 4
40 Estradiol 3-benzoate Phase 4
41 Estradiol valerate Phase 4 979-32-8
42 Estrogens Phase 4
43 Ethinyl estradiol, levonorgestrel drug combination Phase 4
44 Hormone Antagonists Phase 4,Phase 3
45 Hormones Phase 4,Phase 3
46 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3
47 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2
48 Polyestradiol phosphate Phase 4
49
Ampicillin Approved, Vet_approved Phase 2, Phase 3 69-53-4 6249
50
Chlorhexidine Approved, Vet_approved Phase 3 55-56-1 9552079 2713

Interventional clinical trials:

(show top 50) (show all 64)

id Name Status NCT ID Phase Drugs
1 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
2 Does Preoperative Vaginal Preparation With Povidone-iodine Before Cesarean Delivery Reduce the Risk of Endometritis? Completed NCT01437228 Phase 4 povidone- iodine solution.;placebo
3 Doxycycline Prophylaxis at Vacuum Aspiration Trial Completed NCT00547170 Phase 4 Doxycycline pre-operatively;Doxycycline post-operatively
4 Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia Completed NCT01165307 Phase 4 Estradiol 30mcg / Levonorgestrel 150mcg monophasic oral contraceptive pills;Naproxen sodium pills
5 Surgical Success After Laparoscopic vs Abdominal Hysterectomy Recruiting NCT01793584 Phase 4
6 Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis Recruiting NCT02693483 Phase 4 10% povidone iodine
7 Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries Not yet recruiting NCT03248297 Phase 4 Azithromycin;Azithromycin and amoxicillin;Placebo
8 Treatment Utility of Postpartum Antibiotics in Chorioamnionitis Terminated NCT01585129 Phase 4 Postpartum Antibiotics;No postpartum antibiotics
9 Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis Withdrawn NCT01721616 Phase 4 Azithromycin;Cefazolin
10 Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination Completed NCT00964210 Phase 3 Licensed quadrivalent HPV vaccine, Gardasil
11 Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term Completed NCT01633294 Phase 2, Phase 3 Ampicillin + gentamicin
12 Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery Recruiting NCT02915289 Phase 3
13 Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause Not yet recruiting NCT02943655 Phase 3 combined contraceptive pills (microcept);medroxyprogesterone acetate (progest);mefenamic acid (ponstan forte)
14 Empiric Therapy of Mucopurulent Cervicitis (MPC) Terminated NCT01072136 Phase 3 Azithromycin;Cefixime
15 The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea Completed NCT02467543 Phase 2
16 Role of Ginkgo Biloba Extract in IUGR Completed NCT02425436 Phase 2 Ginkgo Biloba Extract
17 Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx Recruiting NCT02977234 Phase 1, Phase 2 Isoamyl 2-Cyanoacrylate
18 Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne Recruiting NCT03076320 Phase 1, Phase 2
19 The Effects of Lymphocyte Therapy on Pregnancy Rate of Patient With Recurrent Implantation Failure Recruiting NCT03267797 Phase 2 lymphocytes
20 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Active, not recruiting NCT00445965 Phase 2
21 The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section Not yet recruiting NCT02742948 Phase 2 ceftriaxone
22 Pharmacokinetics and Safety of Ertapenem in the Postpartum Period Terminated NCT01587495 Phase 1 Ertapenem
23 Correlation Between Inflammatory Markers in Gingival Crevicular Fluid, Serum and Amniotic Fluids in Periodontal Pregnant Women Unknown status NCT02022865
24 Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth: a Randomized Controlled Trial Unknown status NCT01945450 Antibiotic prophylaxis;Ampicillin;Gentamycin;Clindamycin
25 Tumor Bank for Tissue Samples Unknown status NCT01789229
26 The Immune Reactivity of Biofilms in Vaginal Mesh Erosion. Unknown status NCT00564044
27 Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease Completed NCT00115388
28 Uterine Flora During Elective and Urgent Cesarean Sections Completed NCT00500019
29 A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laporoscopy to Detect Endometriosis Completed NCT01464775
30 The Role of Novel Organisms in Acute Endometritis Completed NCT01236131
31 Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine Completed NCT00858832 Methergine
32 Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity Completed NCT00603603
33 Efficacy of Dead Sea Peloid Gel in Chronic Endometritis Completed NCT02680275 Dead Sea Peloid Gel
34 Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection Completed NCT00670020
35 The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery Completed NCT01464840 Azithromycin
36 A Prospective Comparative Study of Induction of Labor With a Cervical Ripening Double Balloon vs Foley Catheter Completed NCT00501033
37 New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma Completed NCT02997787
38 Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls Completed NCT01860963
39 Study of Cervix and Inflammation in Preterm Birth Prediction Completed NCT01007513
40 Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer Completed NCT01170299
41 Timing of Prophylactic Antibiotics for Cesarean Sections Completed NCT00330278 Cefazolin
42 Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization Completed NCT01762098
43 Use of Dexamethasone in Uterine Artery Embolization Completed NCT02056717 Dexamethasone;Normal saline
44 The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney Injuries Completed NCT01333657
45 Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection Completed NCT01235546 Azithromycin and standard of care;Placebo and standard of care
46 Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Adhesions Completed NCT02744807
47 Pelvic Pain in Women With Endometriosis Completed NCT00073801
48 European Active Surveillance Study of LCS12 Recruiting NCT02146950
49 Infertility and Endometriosis Cohort Recruiting NCT01833013
50 Diagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive Treatments Recruiting NCT03169621

Search NIH Clinical Center for Uterine Inflammatory Disease

Genetic Tests for Uterine Inflammatory Disease

Anatomical Context for Uterine Inflammatory Disease

MalaCards organs/tissues related to Uterine Inflammatory Disease:

39
Uterus, Myeloid, Cervix, Placenta, Kidney, Lung

Publications for Uterine Inflammatory Disease

Variations for Uterine Inflammatory Disease

Expression for Uterine Inflammatory Disease

Search GEO for disease gene expression data for Uterine Inflammatory Disease.

Pathways for Uterine Inflammatory Disease

GO Terms for Uterine Inflammatory Disease

Sources for Uterine Inflammatory Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....